magamago
N° messaggi: 2888 -
Iscritto da: 24/3/2012
Grafico Intraday: Recordati SpA
Grafico Storico: Recordati SpA
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. Itâs product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane.
rampani
N° messaggi: 72895 -
Iscritto da: 03/9/2007
This is how chinese make pancakes…
23 di 128-11/2/2018 16:130
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
24 di 128-11/2/2018 16:140
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
25 di 128-11/2/2018 16:140
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
26 di 128-11/2/2018 16:150
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
27 di 128-11/2/2018 16:150
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
28 di 128-11/2/2018 16:150
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
29 di 128-11/2/2018 16:160
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
30 di 128-11/2/2018 16:160
recepito
N° messaggi: 337 -
Iscritto da: 23/2/2010
31 di 128-02/5/2018 20:390
rampani
N° messaggi: 72895 -
Iscritto da: 03/9/2007
32 di 128-04/5/2018 12:320
eliconia
N° messaggi: 4074 -
Iscritto da: 18/1/2013
Dai cazzo che vendete a fare ma siete invertebrati look at the figure
33 di 128-07/5/2018 17:050
peppa1984
N° messaggi: 226 -
Iscritto da: 05/4/2016
Che si dice qui?
Io entrato a 30,60
34 di 128-07/5/2018 17:100
rampani
N° messaggi: 72895 -
Iscritto da: 03/9/2007
La FIG.a mettelealiiiiiii
35 di 128-16/5/2018 21:460
dibbo1
N° messaggi: 2827 -
Iscritto da: 08/10/2013
Exclusive: CVC puts $9 billion Recordati bid on hold as political uncertainty weighs
Pamela Barbaglia, Stephen Jewkes
5 Min Read
LONDON/MILAN (Reuters) - Buyout fund CVC Capital Partners held talks with Italian drugmaker Recordati (RECI.MI) over a possible 8 billion euro ($9.4 billion) takeover, but has put the deal on hold due to concerns about the hefty price tag and political uncertainty, three sources familiar with the matter said.
Chris Stadler Managing Partner, CVC Capital, speaks at the Milken Institute 21st Global Conference in Beverly Hills, California, U.S. May 1, 2018. REUTERS/Mike Blake
Recordati, a family-owned maker of cardiovascular and rare diseases drugs, is Italy’s biggest listed pharmaceutical company with a market value of 6.4 billion euros ($7.6 billion).
The Recordati family, which controls about 51 percent of the company via their Fimei holding, has been sounding out potential bidders in the last two years following the death of the company’s former boss Giovanni in 2016, the sources said.
The family does not want to sell on the cheap. An 8 billion euro bid would imply a premium of 25 percent for the whole business, the sources said.
London-based CVC began talks with Recordati last year but one of the sources said it decided to put the deal on hold shortly before Italy’s national elections on March 4, which resulted in a strong showing for anti-establishment parties and a hung parliament.
“There was momentum in negotiations in late 2017 but they waited too long. Right now there is no appetite to make big bets in Italy,” the source said.
CVC would need to borrow cash to finance a takeover of Recordati and raise additional funds by distributing shares in the group to its own investors - a task made more challenging by Italy’s protracted political stalemate.
“Recordati would be a great investment for CVC but it’s hard for them to justify such a high price with the ongoing political uncertainty,” the source said.
Financial markets and investors had been relatively resilient during 10 weeks of inconclusive talks between Italian political parties seeking to form a government.
That changed this week as the anti-establishment 5-Star Movement and the far-right League neared a deal to form a coalition government and challenge European fiscal rules.
On Wednesday, Italy’s borrowing costs jumped and its stocks slid after a draft program for the potential government revealed plans to demand 250 billion euros of debt forgiveness.
A second source with knowledge of the negotiations said the clouded political outlook had played a role in CVC’s decision to sit on the fence for now, adding no other bidders were currently in talks with the Recordati family.
CVC could re-examine the deal once the political situation stabilizes, the first source said.
CVC declined to comment, while Recordati was not immediately available for comment.
Recordati, led by Chief Executive Andrea Recordati and Chairman Alberto Recordati, was founded in 1926 and has revenues of 1.2 billion euros and net income of 288 million euros. Almost 80 percent of its overall revenues are made outside Italy.
The Milan-based company employs more than 4,000 people and operates in Western Europe as well as Russia and various Central and Eastern European countries, the United States, Canada, North Africa and Latin America
36 di 128-29/6/2018 20:180
dibbo1
N° messaggi: 2827 -
Iscritto da: 08/10/2013
Informazioni sulla discussione
Tutti
Torna alla Lista
Aggiorna Lista
This is how chinese make pancakes…